Albumin infusion in patients undergoing large-volume paracentesis: A meta-analysis of randomized trials
Albumin infusion reduces the incidence of postparacentesis circulatory dysfunction among patients with cirrhosis and tense ascites, as compared with no treatment. Treatment alternatives to albumin, such as artificial colloids and vasoconstrictors, have been widely investigated. The aim of this meta‐...
Uloženo v:
| Vydáno v: | Hepatology (Baltimore, Md.) Ročník 55; číslo 4; s. 1172 - 1181 |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
01.04.2012
Wiley Wolters Kluwer Health, Inc |
| Témata: | |
| ISSN: | 0270-9139, 1527-3350, 1527-3350 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Albumin infusion reduces the incidence of postparacentesis circulatory dysfunction among patients with cirrhosis and tense ascites, as compared with no treatment. Treatment alternatives to albumin, such as artificial colloids and vasoconstrictors, have been widely investigated. The aim of this meta‐analysis was to determine whether morbidity and mortality differ between patients receiving albumin versus alternative treatments. The meta‐analysis included randomized trials evaluating albumin infusion in patients with tense ascites. Primary endpoints were postparacentesis circulatory dysfunction, hyponatremia, and mortality. Eligible trials were sought by multiple methods, including computer searches of bibliographic and databases and the Cochrane Library. Results were quantitatively combined under a fixed‐effects model. Seventeen trials with 1,225 total patients were included. There was no evidence of heterogeneity or publication bias. Compared with alternative treatments, albumin reduced the incidence of postparacentesis circulatory dysfunction (odds ratio [OR], 0.39; 95% confidence interval [CI], 0.27‐0.55). Significant reductions in that complication by albumin were also shown in subgroup analyses versus each of the other volume expanders tested (e.g., dextran, gelatin, hydroxyethyl starch, and hypertonic saline). The occurrence of hyponatremia was also decreased by albumin, compared with alternative treatments (OR, 0.58; 95% CI, 0.39‐0.87). In addition, mortality was lower in patients receiving albumin than alternative treatments (OR, 0.64; 95% CI, 0.41‐0.98). Conclusions: This meta‐analysis provides evidence that albumin reduces morbidity and mortality among patients with tense ascites undergoing large‐volume paracentesis, as compared with alternative treatments investigated thus far. (HEPATOLOGY 2012) |
|---|---|
| AbstractList | Albumin infusion reduces the incidence of postparacentesis circulatory dysfunction among patients with cirrhosis and tense ascites, as compared with no treatment. Treatment alternatives to albumin, such as artificial colloids and vasoconstrictors, have been widely investigated. The aim of this meta-analysis was to determine whether morbidity and mortality differ between patients receiving albumin versus alternative treatments. The meta-analysis included randomized trials evaluating albumin infusion in patients with tense ascites. Primary endpoints were postparacentesis circulatory dysfunction, hyponatremia, and mortality. Eligible trials were sought by multiple methods, including computer searches of bibliographic and abstract databases and the Cochrane Library. Results were quantitatively combined under a fixed-effects model. Seventeen trials with 1,225 total patients were included. There was no evidence of heterogeneity or publication bias. Compared with alternative treatments, albumin reduced the incidence of postparacentesis circulatory dysfunction (odds ratio [OR], 0.39; 95% confidence interval [CI], 0.27-0.55). Significant reductions in that complication by albumin were also shown in subgroup analyses versus each of the other volume expanders tested (e.g., dextran, gelatin, hydroxyethyl starch, and hypertonic saline). The occurrence of hyponatremia was also decreased by albumin, compared with alternative treatments (OR, 0.58; 95% CI, 0.39-0.87). In addition, mortality was lower in patients receiving albumin than alternative treatments (OR, 0.64; 95% CI, 0.41-0.98).
This meta-analysis provides evidence that albumin reduces morbidity and mortality among patients with tense ascites undergoing large-volume paracentesis, as compared with alternative treatments investigated thus far. Albumin infusion reduces the incidence of postparacentesis circulatory dysfunction among patients with cirrhosis and tense ascites, as compared with no treatment. Treatment alternatives to albumin, such as artificial colloids and vasoconstrictors, have been widely investigated. The aim of this meta-analysis was to determine whether morbidity and mortality differ between patients receiving albumin versus alternative treatments. The meta-analysis included randomized trials evaluating albumin infusion in patients with tense ascites. Primary endpoints were postparacentesis circulatory dysfunction, hyponatremia, and mortality. Eligible trials were sought by multiple methods, including computer searches of bibliographic and abstract databases and the Cochrane Library. Results were quantitatively combined under a fixed-effects model. Seventeen trials with 1,225 total patients were included. There was no evidence of heterogeneity or publication bias. Compared with alternative treatments, albumin reduced the incidence of postparacentesis circulatory dysfunction (odds ratio [OR], 0.39; 95% confidence interval [CI], 0.27-0.55). Significant reductions in that complication by albumin were also shown in subgroup analyses versus each of the other volume expanders tested (e.g., dextran, gelatin, hydroxyethyl starch, and hypertonic saline). The occurrence of hyponatremia was also decreased by albumin, compared with alternative treatments (OR, 0.58; 95% CI, 0.39-0.87). In addition, mortality was lower in patients receiving albumin than alternative treatments (OR, 0.64; 95% CI, 0.41-0.98).UNLABELLEDAlbumin infusion reduces the incidence of postparacentesis circulatory dysfunction among patients with cirrhosis and tense ascites, as compared with no treatment. Treatment alternatives to albumin, such as artificial colloids and vasoconstrictors, have been widely investigated. The aim of this meta-analysis was to determine whether morbidity and mortality differ between patients receiving albumin versus alternative treatments. The meta-analysis included randomized trials evaluating albumin infusion in patients with tense ascites. Primary endpoints were postparacentesis circulatory dysfunction, hyponatremia, and mortality. Eligible trials were sought by multiple methods, including computer searches of bibliographic and abstract databases and the Cochrane Library. Results were quantitatively combined under a fixed-effects model. Seventeen trials with 1,225 total patients were included. There was no evidence of heterogeneity or publication bias. Compared with alternative treatments, albumin reduced the incidence of postparacentesis circulatory dysfunction (odds ratio [OR], 0.39; 95% confidence interval [CI], 0.27-0.55). Significant reductions in that complication by albumin were also shown in subgroup analyses versus each of the other volume expanders tested (e.g., dextran, gelatin, hydroxyethyl starch, and hypertonic saline). The occurrence of hyponatremia was also decreased by albumin, compared with alternative treatments (OR, 0.58; 95% CI, 0.39-0.87). In addition, mortality was lower in patients receiving albumin than alternative treatments (OR, 0.64; 95% CI, 0.41-0.98).This meta-analysis provides evidence that albumin reduces morbidity and mortality among patients with tense ascites undergoing large-volume paracentesis, as compared with alternative treatments investigated thus far.CONCLUSIONSThis meta-analysis provides evidence that albumin reduces morbidity and mortality among patients with tense ascites undergoing large-volume paracentesis, as compared with alternative treatments investigated thus far. Albumin infusion reduces the incidence of postparacentesis circulatory dysfunction among patients with cirrhosis and tense ascites, as compared with no treatment. Treatment alternatives to albumin, such as artificial colloids and vasoconstrictors, have been widely investigated. The aim of this meta-analysis was to determine whether morbidity and mortality differ between patients receiving albumin versus alternative treatments. The meta-analysis included randomized trials evaluating albumin infusion in patients with tense ascites. Primary endpoints were postparacentesis circulatory dysfunction, hyponatremia, and mortality. Eligible trials were sought by multiple methods, including computer searches of bibliographic and abstract databases and the Cochrane Library. Results were quantitatively combined under a fixed-effects model. Seventeen trials with 1,225 total patients were included. There was no evidence of heterogeneity or publication bias. Compared with alternative treatments, albumin reduced the incidence of postparacentesis circulatory dysfunction (odds ratio [OR], 0.39; 95% confidence interval [CI], 0.27-0.55). Significant reductions in that complication by albumin were also shown in subgroup analyses versus each of the other volume expanders tested (e.g., dextran, gelatin, hydroxyethyl starch, and hypertonic saline). The occurrence of hyponatremia was also decreased by albumin, compared with alternative treatments (OR, 0.58; 95% CI, 0.39-0.87). In addition, mortality was lower in patients receiving albumin than alternative treatments (OR, 0.64; 95% CI, 0.41-0.98). Conclusions: This meta-analysis provides evidence that albumin reduces morbidity and mortality among patients with tense ascites undergoing large-volume paracentesis, as compared with alternative treatments investigated thus far. (HEPATOLOGY 2012) Albumin infusion reduces the incidence of postparacentesis circulatory dysfunction among patients with cirrhosis and tense ascites, as compared with no treatment. Treatment alternatives to albumin, such as artificial colloids and vasoconstrictors, have been widely investigated. The aim of this meta‐analysis was to determine whether morbidity and mortality differ between patients receiving albumin versus alternative treatments. The meta‐analysis included randomized trials evaluating albumin infusion in patients with tense ascites. Primary endpoints were postparacentesis circulatory dysfunction, hyponatremia, and mortality. Eligible trials were sought by multiple methods, including computer searches of bibliographic and databases and the Cochrane Library. Results were quantitatively combined under a fixed‐effects model. Seventeen trials with 1,225 total patients were included. There was no evidence of heterogeneity or publication bias. Compared with alternative treatments, albumin reduced the incidence of postparacentesis circulatory dysfunction (odds ratio [OR], 0.39; 95% confidence interval [CI], 0.27‐0.55). Significant reductions in that complication by albumin were also shown in subgroup analyses versus each of the other volume expanders tested (e.g., dextran, gelatin, hydroxyethyl starch, and hypertonic saline). The occurrence of hyponatremia was also decreased by albumin, compared with alternative treatments (OR, 0.58; 95% CI, 0.39‐0.87). In addition, mortality was lower in patients receiving albumin than alternative treatments (OR, 0.64; 95% CI, 0.41‐0.98). Conclusions: This meta‐analysis provides evidence that albumin reduces morbidity and mortality among patients with tense ascites undergoing large‐volume paracentesis, as compared with alternative treatments investigated thus far. (HEPATOLOGY 2012) |
| Author | Wilkes, Mahlon M. Navickis, Roberta J. Caraceni, Paolo Bernardi, Mauro |
| Author_xml | – sequence: 1 givenname: Mauro surname: Bernardi fullname: Bernardi, Mauro email: mauro.bernardi@unibo.it organization: Dipartimento di Medicina Clinica, Alma Mater Studiorum-Università di Bologna, Semeiotica Medica-Policlinico S. Orsola-Malpighi, Bologna, Italy – sequence: 2 givenname: Paolo surname: Caraceni fullname: Caraceni, Paolo organization: Dipartimento di Medicina Clinica, Alma Mater Studiorum-Università di Bologna, Semeiotica Medica-Policlinico S. Orsola-Malpighi, Bologna, Italy – sequence: 3 givenname: Roberta J. surname: Navickis fullname: Navickis, Roberta J. organization: Hygeia Associates, Grass Valley, CA – sequence: 4 givenname: Mahlon M. surname: Wilkes fullname: Wilkes, Mahlon M. organization: Hygeia Associates, Grass Valley, CA |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25802003$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/22095893$$D View this record in MEDLINE/PubMed |
| BookMark | eNp90V1rFDEUBuAgFbutXvgHZEBEvZg2H5OZpHdLra2wqGhF8CacmUnW1EyyJjPq-uvNutsKBXuVEJ73QM57gPZ88BqhxwQfEYzp8Ve9OqJVI-p7aEY4bUrGON5DM0wbXErC5D46SOkKYywrKh6gfUqx5EKyGVrOXTsN1hfWmynZsLkUKxit9mMqJt_ruAzWLwsHcanLH8FNg84gQpeFTjadFPNi0COU4MGt80MRTBHB92Gwv3VfjNGCSw_RfZMP_Wh3HqJPr88uTy_KxbvzN6fzRdlxXtVl3zZGA8VgmO4lAVFLCk3Ljey5JLSVhjegeWsYCMKE6SsgImuDMa9Jy9kher6du4rh-6TTqAabOu0ceB2mpGTNKiFxs5Ev7pQkm4pLSVmmT2_RqzDF_N2NqgQhtGJVVk92amoH3atVtAPEtbpedgbPdgBSB87kJXU2_XNcYIrxxr3cui6GlKI2N4RgtSlc5cLV38KzPb5lOzvm-oIfI1h3V-KndXr9_9Hq4uz9daLcJmwa9a-bBMRvqm5Yw9Xnt-fq4-LVhy_ykqma_QHv-Mrx |
| CODEN | HPTLD9 |
| CitedBy_id | crossref_primary_10_1159_000446043 crossref_primary_10_1055_s_0042_1759613 crossref_primary_10_7759_cureus_14619 crossref_primary_10_1016_j_jhep_2024_03_031 crossref_primary_10_1016_j_jceh_2015_03_002 crossref_primary_10_1002_lt_25621 crossref_primary_10_1213_ANE_0b013e3182860fff crossref_primary_10_1097_01_ELX_0000433597_15423_45 crossref_primary_10_1136_bmjopen_2015_010132 crossref_primary_10_1016_j_medine_2015_05_002 crossref_primary_10_1016_j_ajem_2017_12_047 crossref_primary_10_1055_a_1208_9277 crossref_primary_10_1001_jamanetworkopen_2023_22048 crossref_primary_10_1097_01_CDR_0001094500_13144_df crossref_primary_10_1007_s12072_015_9665_6 crossref_primary_10_1007_s12325_023_02430_3 crossref_primary_10_1093_gastro_goae097 crossref_primary_10_1097_OGX_0b013e3182a878c6 crossref_primary_10_3402_jchimp_v6_32421 crossref_primary_10_1097_MCG_0000000000000735 crossref_primary_10_1002_lt_24763 crossref_primary_10_1016_j_clnesp_2025_03_014 crossref_primary_10_1016_j_suc_2021_09_005 crossref_primary_10_1016_j_jvir_2018_10_006 crossref_primary_10_1053_j_gastro_2016_09_016 crossref_primary_10_1177_2050640614560452 crossref_primary_10_1155_2022_2245491 crossref_primary_10_1007_s11938_024_00461_5 crossref_primary_10_1055_a_2015_1290 crossref_primary_10_1007_s00508_023_02229_w crossref_primary_10_1016_j_jceh_2014_08_007 crossref_primary_10_1007_s11901_023_00625_4 crossref_primary_10_1016_j_jceh_2023_01_009 crossref_primary_10_1272_manms_21_221 crossref_primary_10_1007_s13304_024_01964_7 crossref_primary_10_1007_s00101_013_2197_3 crossref_primary_10_1136_bmjopen_2018_023754 crossref_primary_10_1093_gastro_gox009 crossref_primary_10_1002_clc_22489 crossref_primary_10_1016_j_jhep_2017_06_010 crossref_primary_10_1111_jgh_15253 crossref_primary_10_1136_gutjnl_2020_321790 crossref_primary_10_1007_s00261_017_1406_y crossref_primary_10_1002_hsr2_1926 crossref_primary_10_1136_bmj_m2687 crossref_primary_10_1111_apt_17659 crossref_primary_10_1002_jhm_70037 crossref_primary_10_1016_j_jhep_2015_07_004 crossref_primary_10_1136_bmjopen_2018_024159 crossref_primary_10_1148_radiol_2021201960 crossref_primary_10_1002_ygh2_402 crossref_primary_10_1097_COC_0000000000000618 crossref_primary_10_1002_jgh3_12468 crossref_primary_10_1007_s12257_022_0104_y crossref_primary_10_1007_s12072_019_09961_4 crossref_primary_10_1053_j_sempedsurg_2014_06_003 crossref_primary_10_1177_1060028020935575 crossref_primary_10_1016_j_cld_2020_08_007 crossref_primary_10_3350_cmh_2015_21_4_349 crossref_primary_10_1002_ygh2_395 crossref_primary_10_1053_j_gastro_2023_10_016 crossref_primary_10_1007_s11901_020_00521_1 crossref_primary_10_1002_ygh2_399 crossref_primary_10_1016_j_cld_2022_08_010 crossref_primary_10_1016_j_mcna_2013_09_006 crossref_primary_10_1111_jcpt_13461 crossref_primary_10_1177_0897190018816252 crossref_primary_10_1002_cld_462 crossref_primary_10_1016_j_jcrc_2016_04_019 crossref_primary_10_14309_ajg_0000000000002767 crossref_primary_10_1007_s00535_016_1216_y crossref_primary_10_1056_NEJMra2215289 crossref_primary_10_1097_TP_0000000000004771 crossref_primary_10_1016_j_cgh_2012_06_027 crossref_primary_10_1016_j_cld_2021_01_010 crossref_primary_10_1186_s12876_015_0389_9 crossref_primary_10_1016_j_ejim_2023_07_003 crossref_primary_10_7717_peerj_7855 crossref_primary_10_1111_liv_12549 crossref_primary_10_5604_01_3001_0012_7195 crossref_primary_10_1016_j_emc_2016_08_006 crossref_primary_10_1111_liv_12545 crossref_primary_10_1038_s41575_018_0045_2 crossref_primary_10_1002_hep_26338 crossref_primary_10_1016_j_aohep_2023_101150 crossref_primary_10_36290_vnl_2024_104 crossref_primary_10_3390_jcm11195928 crossref_primary_10_1007_s10396_021_01094_2 crossref_primary_10_1002_cld_202 crossref_primary_10_3748_wjg_v25_i8_888 crossref_primary_10_1016_j_mcna_2022_12_004 crossref_primary_10_1111_hepr_13937 crossref_primary_10_1016_j_aohep_2022_100673 crossref_primary_10_1155_2013_959474 crossref_primary_10_1016_j_ejim_2013_05_015 crossref_primary_10_1007_s10620_016_4140_3 crossref_primary_10_1111_jgh_13421 crossref_primary_10_1097_CCM_0000000000004192 crossref_primary_10_1136_gutjnl_2016_311999 crossref_primary_10_1007_s12072_018_9894_6 crossref_primary_10_1310_hpj5006_446 crossref_primary_10_1080_17474124_2018_1555469 crossref_primary_10_7759_cureus_16084 crossref_primary_10_1016_j_ctarc_2022_100653 crossref_primary_10_1002_hep_26359 crossref_primary_10_1016_j_jfma_2025_01_002 crossref_primary_10_1016_j_jhep_2017_01_011 crossref_primary_10_1097_MJT_0000000000001046 crossref_primary_10_1016_j_dld_2021_12_007 crossref_primary_10_1111_jog_12763 crossref_primary_10_14309_ajg_0000000000000786 crossref_primary_10_1111_ajt_13790 crossref_primary_10_3390_ijms241612979 crossref_primary_10_1016_j_idc_2012_08_009 crossref_primary_10_1016_j_dld_2015_11_008 crossref_primary_10_1111_jgh_12709 crossref_primary_10_1002_hep_27105 crossref_primary_10_1016_j_jhep_2018_03_024 crossref_primary_10_1002_hep_27106 crossref_primary_10_1038_s41395_018_0185_6 crossref_primary_10_1177_08850666251345408 crossref_primary_10_1007_s12072_018_09923_2 crossref_primary_10_3390_jcm12010107 crossref_primary_10_5604_01_3001_0012_0916 crossref_primary_10_3748_wjg_v28_i33_4773 crossref_primary_10_3390_cimb47050303 crossref_primary_10_1177_1049909118755378 crossref_primary_10_1080_17474124_2017_1275961 crossref_primary_10_1177_0018578719828341 crossref_primary_10_1016_j_cgh_2012_11_007 crossref_primary_10_1177_0300060517735231 crossref_primary_10_1186_1471_230X_14_18 crossref_primary_10_4254_wjh_v17_i6_106418 crossref_primary_10_1007_s40140_024_00613_4 crossref_primary_10_1055_s_0042_1745863 crossref_primary_10_3390_diseases11020068 crossref_primary_10_1007_s10620_015_3578_z crossref_primary_10_1097_CM9_0000000000001661 crossref_primary_10_1016_j_cld_2019_06_002 crossref_primary_10_1007_s00063_021_00875_4 crossref_primary_10_1007_s11938_019_00227_4 crossref_primary_10_1007_s10620_016_4248_5 crossref_primary_10_1097_HEP_0000000000000521 crossref_primary_10_1007_s00535_021_01788_x crossref_primary_10_1111_hepr_13860 crossref_primary_10_1007_s12072_017_9815_0 crossref_primary_10_3350_cmh_2024_0870 crossref_primary_10_1111_hepr_12769 crossref_primary_10_1007_s00134_018_5313_7 crossref_primary_10_1016_j_cgh_2023_03_019 crossref_primary_10_2478_jtim_2020_0035 crossref_primary_10_3350_cmh_2022_0104 crossref_primary_10_3390_jcm10225226 crossref_primary_10_36290_vnl_2020_062 crossref_primary_10_1097_TP_0000000000004803 crossref_primary_10_1038_nm_3553 crossref_primary_10_1155_2013_295153 crossref_primary_10_1016_j_jceh_2023_101306 crossref_primary_10_3390_jcm10194590 crossref_primary_10_1016_j_jpba_2017_04_023 crossref_primary_10_7748_ns_2019_e11344 crossref_primary_10_2215_CJN_12451018 crossref_primary_10_1016_j_mcna_2015_05_001 crossref_primary_10_1016_S0140_6736_18_30948_6 crossref_primary_10_2147_CEG_S323778 crossref_primary_10_1002_hep_30412 crossref_primary_10_1080_20009666_2017_1302704 crossref_primary_10_1016_j_medin_2014_12_007 crossref_primary_10_12788_jhm_3105 crossref_primary_10_2147_HMER_S264231 crossref_primary_10_4254_wjh_v16_i12_1377 crossref_primary_10_1002_lt_25384 crossref_primary_10_3748_wjg_v25_i28_3738 crossref_primary_10_1080_17474124_2016_1196132 crossref_primary_10_1007_s11739_012_0802_0 crossref_primary_10_1016_j_jcrc_2015_12_019 crossref_primary_10_1136_bmjopen_2018_025664 crossref_primary_10_1016_j_jceh_2021_09_008 crossref_primary_10_1016_j_accpm_2019_06_014 crossref_primary_10_1016_j_ejso_2016_09_008 crossref_primary_10_1111_aas_14479 crossref_primary_10_3390_jcm12030934 crossref_primary_10_1016_j_jhep_2014_04_012 crossref_primary_10_3350_cmh_2018_1005 crossref_primary_10_1016_j_aohep_2021_100541 crossref_primary_10_1002_cld_270 crossref_primary_10_1016_j_aohep_2021_100547 crossref_primary_10_1016_j_aohep_2022_100708 crossref_primary_10_1016_j_bpa_2012_10_005 crossref_primary_10_4254_wjh_v8_i7_345 crossref_primary_10_1016_j_ejps_2021_105923 crossref_primary_10_1111_hepr_13678 crossref_primary_10_1155_2015_912839 crossref_primary_10_1007_s12072_023_10536_7 crossref_primary_10_1002_ueg2_12539 crossref_primary_10_1007_s00508_017_1262_3 crossref_primary_10_4254_wjh_v13_i4_421 crossref_primary_10_1016_j_cld_2022_01_004 crossref_primary_10_1016_j_jhep_2015_06_019 crossref_primary_10_1097_MEG_0000000000001277 crossref_primary_10_1016_j_cld_2022_01_002 crossref_primary_10_1097_CRD_0000000000000379 crossref_primary_10_1016_j_jacr_2016_04_017 crossref_primary_10_1186_s13561_019_0237_7 crossref_primary_10_1097_MEG_0000000000001932 crossref_primary_10_12788_jhm_3695 crossref_primary_10_1007_s00423_015_1356_1 crossref_primary_10_1111_imj_13741 crossref_primary_10_1136_gutjnl_2019_318843 crossref_primary_10_1177_2050640620910339 crossref_primary_10_3390_jcm4010085 crossref_primary_10_1016_j_amjmed_2012_09_016 crossref_primary_10_1038_s41572_018_0022_7 |
| Cites_doi | 10.1136/bmj.323.7303.42 10.1002/hep.510280337 10.1016/S0016-5085(96)70068-9 10.1016/j.jhep.2005.10.013 10.1111/j.1478-3231.2009.02027_1.x 10.1002/hep.23006 10.1016/j.ajg.2010.01.006 10.1053/gast.1997.v113.pm9247479 10.1111/j.1478-3231.2008.01734.x 10.1002/hep.20720 10.1016/0016-5085(90)90481-F 10.1111/j.1572-0241.2008.01787.x 10.1016/S0168-8278(07)61830-3 10.1002/hep.1840130416 10.1002/hep.22913 10.1111/j.1365-2796.2006.01654.x 10.1111/j.1478-3231.2010.02272.x 10.1053/jhep.2003.50169 10.1016/S0168-8278(99)80194-9 10.1002/hep.21412 10.1111/j.1440-1746.2006.04182.x 10.1111/j.1478-3231.2005.01188.x 10.1016/S0168-8278(97)80081-5 10.1016/0016-5085(88)90691-9 10.1080/00365520902912555 10.1136/bmj.315.7109.629 10.1002/hep.22853 10.1136/gut.50.1.90 10.1016/S0140-6736(85)92147-6 10.1111/j.1399-6576.1993.tb03741.x 10.1016/S1665-2681(19)32189-1 10.1016/0168-8278(92)90176-P 10.1016/S0168-8278(99)80329-8 10.1097/00042737-199801000-00002 10.1111/j.1440-1746.2005.03982.x 10.1002/hep.20829 10.1055/s-2008-1040320 10.1056/NEJMoa0801209 10.1016/S0168-8278(98)80288-2 10.1111/j.1600-0676.1993.tb00637.x 10.1001/jama.299.10.1166 10.1016/j.jhep.2010.05.004 10.1136/gut.31.2.204 10.1016/0016-5085(87)91007-9 10.3748/wjg.v12.i9.1403 10.1111/j.1478-3231.2010.02293.x |
| ContentType | Journal Article |
| Copyright | Copyright © 2011 American Association for the Study of Liver Diseases 2015 INIST-CNRS Copyright © 2011 American Association for the Study of Liver Diseases. |
| Copyright_xml | – notice: Copyright © 2011 American Association for the Study of Liver Diseases – notice: 2015 INIST-CNRS – notice: Copyright © 2011 American Association for the Study of Liver Diseases. |
| DBID | BSCLL AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7T5 7TM 7TO 7U9 H94 K9. 7X8 |
| DOI | 10.1002/hep.24786 |
| DatabaseName | Istex CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Virology and AIDS Abstracts Oncogenes and Growth Factors Abstracts Nucleic Acids Abstracts MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic AIDS and Cancer Research Abstracts AIDS and Cancer Research Abstracts |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1527-3350 |
| EndPage | 1181 |
| ExternalDocumentID | 3892648481 22095893 25802003 10_1002_hep_24786 HEP24786 ark_67375_WNG_SLDRZ9T3_6 |
| Genre | article Research Support, Non-U.S. Gov't Meta-Analysis Journal Article |
| GroupedDBID | --- --K .3N .55 .GA .GJ .Y3 05W 0R~ 10A 186 1B1 1CY 1L6 1OC 1ZS 1~5 31~ 33P 3O- 3SF 3WU 4.4 4G. 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5RE 5VS 7-5 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAEDT AAESR AAEVG AALRI AAMMB AANHP AAONW AAQFI AAQQT AAQXK AASGY AAXRX AAXUO AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABLJU ABMAC ABOCM ABPVW ABWVN ABXGK ACAHQ ACBWZ ACCZN ACGFS ACLDA ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ACZKN ADBBV ADEOM ADIZJ ADKYN ADMGS ADMUD ADNMO ADOZA ADSXY ADXAS ADZMN AECAP AEFGJ AEIMD AENEX AFBPY AFFNX AFGKR AFNMH AFUWQ AFZJQ AGQPQ AGXDD AHMBA AHQVU AIACR AIDQK AIDYY AIQQE AIURR AJAOE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BAWUL BDRZF BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 E3Z EBS EJD F00 F01 F04 F5P FD8 FDB FEDTE FGOYB FUBAC G-S G.N GNP GODZA H.X HBH HF~ HHY HHZ HVGLF HZ~ IHE IX1 J0M J5H JPC KBYEO KQQ LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M41 M65 MEWTI MJL MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N4W N9A NF~ NNB NQ- O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K R2- RIG RIWAO RJQFR ROL RPZ RX1 RYL SEW SSZ SUPJJ TEORI UB1 V2E V9Y W2D W8V W99 WBKPD WH7 WHWMO WIB WIH WIJ WIK WJL WOHZO WQJ WVDHM WXI WXSBR X7M XG1 XV2 ZGI ZXP ZZTAW ~IA ~WT 1OB 24P AAHHS ACCFJ ADZOD AEEZP AEQDE AEUQT AFPWT AIWBW AJBDE RGB RWI WIN WRC WUP 9DU AAYXX CITATION O8X IQODW CGR CUY CVF ECM EIF NPM 7T5 7TM 7TO 7U9 H94 K9. 7X8 |
| ID | FETCH-LOGICAL-c5546-db7fea20af3ed91a8692a7b5f9d5912b9f57ae5bf3a8138fd4a180aff00561b53 |
| IEDL.DBID | DRFUL |
| ISICitedReferencesCount | 249 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000302069900021&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0270-9139 1527-3350 |
| IngestDate | Fri Jul 11 13:45:02 EDT 2025 Fri Jul 11 08:29:23 EDT 2025 Sat Nov 29 14:25:08 EST 2025 Mon Jul 21 06:04:40 EDT 2025 Mon Jul 21 09:14:41 EDT 2025 Tue Nov 18 21:56:34 EST 2025 Sat Nov 29 05:40:20 EST 2025 Wed Jan 22 16:26:59 EST 2025 Sun Sep 21 06:18:35 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | Human Albumin Paracentesis Gastroenterology |
| Language | English |
| License | CC BY 4.0 Copyright © 2011 American Association for the Study of Liver Diseases. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c5546-db7fea20af3ed91a8692a7b5f9d5912b9f57ae5bf3a8138fd4a180aff00561b53 |
| Notes | ArticleID:HEP24786 istex:EB66DE9D28105CAE80B01D40E586C8A8C3DBFA90 ark:/67375/WNG-SLDRZ9T3-6 This investigation was supported through an unrestricted grant from CSL Behring, King of Prussia, PA. Potential conflict of interest: Dr. Navickis and Dr. Wilkes received grants from CSL Behring. fax: (+39) 051 636 2930 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep.24786 |
| PMID | 22095893 |
| PQID | 1748112434 |
| PQPubID | 996352 |
| PageCount | 10 |
| ParticipantIDs | proquest_miscellaneous_963489075 proquest_miscellaneous_1753459923 proquest_journals_1748112434 pubmed_primary_22095893 pascalfrancis_primary_25802003 crossref_primary_10_1002_hep_24786 crossref_citationtrail_10_1002_hep_24786 wiley_primary_10_1002_hep_24786_HEP24786 istex_primary_ark_67375_WNG_SLDRZ9T3_6 |
| PublicationCentury | 2000 |
| PublicationDate | April 2012 |
| PublicationDateYYYYMMDD | 2012-04-01 |
| PublicationDate_xml | – month: 04 year: 2012 text: April 2012 |
| PublicationDecade | 2010 |
| PublicationPlace | Hoboken |
| PublicationPlace_xml | – name: Hoboken – name: Hoboken, NJ – name: United States |
| PublicationTitle | Hepatology (Baltimore, Md.) |
| PublicationTitleAlternate | Hepatology |
| PublicationYear | 2012 |
| Publisher | Wiley Subscription Services, Inc., A Wiley Company Wiley Wolters Kluwer Health, Inc |
| Publisher_xml | – name: Wiley Subscription Services, Inc., A Wiley Company – name: Wiley – name: Wolters Kluwer Health, Inc |
| References | Arroyo V. Human serum albumin: not just a plasma volume expander. HEPATOLOGY 2009; 50: 355-357. Singh V, Dheerendra PC, Singh B, Nain CK, Chawla D, Sharma N, et al. Midodrine versus albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotics: a randomized pilot study. Am J Gastroenterol 2008; 103: 1399-1405. Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008; 359: 1018-1026. Romanelli RG, La Villa G, Barletta G, Vizzutti F, Lanini F, Arena U, et al. Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial. World J Gastroenterol 2006; 12: 1403-1407. Appenrodt B, Wolf A, Grunhage F, Trebicka J, Schepke M, Rabe C, et al. Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study. Liver Int 2008; 28: 1019-1025. Jalan R, Schnurr K, Mookerjee RP, Sen S, Cheshire L, Hodges S, et al. Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality. HEPATOLOGY 2009; 50: 555-564. Fernández J, Monteagudo J, Bargallo X, Jiménez W, Bosch J, Arroyo V, Navasa M. A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis. HEPATOLOGY 2005; 42: 627-634. Luca A, García-Pagán JC, Bosch J, Feu F, Jiménez W, Ginès A, et al. Beneficial effects of intravenous albumin infusion on the hemodynamic and humoral changes after total paracentesis. HEPATOLOGY 1995; 22: 753-758. Ginès A, Fernández-Esparrach G, Monescillo A, Vila C, Domènech E, Abecasis R, et al. Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology 1996; 111: 1002-1010. Cholongitas E, Papatheodoridis GV, Manesis EK, Burroughs AK, Archimandritis AJ. Spontaneous bacterial peritonitis in cirrhotic patients: is prophylactic propranolol therapy beneficial? J Gastroenterol Hepatol 2006; 21: 581-587. Abdel-Khalek EE, Arif SE. Randomized trial comparing human albumin and hydroxyethyl starch 6% as plasma expanders for treatment of patients with liver cirrhosis and tense ascites following large volume paracentesis. Arab J Gastroenterol 2010; 11: 24-29. Schindler C, Ramadori G. Albumin substitution improves urinary sodium excretion and diuresis in patients with liver cirrhosis and refractory ascites. J Hepatol 1999; 31: 1132. Jalan R, Mookerjee RP, Cheshire LM, Williams R, Davies NA. Albumin infusion for severe hyponatremia in patients with refractory ascites: a randomized clinical trial. J Hepatol 2007; 46: S95. Quinlan GJ, Martin GS, Evans TW. Albumin: biochemical properties and therapeutic potential. HEPATOLOGY 2005; 41: 1211-1219. Alessandria C, Elia C, Mezzabotta L, Risso A, Andrealli A, Spandre M, et al. Prevention of paracentesis-induced circulatory dysfunction in cirrhosis: standard vs half albumin doses. A prospective, randomized, unblinded pilot study. Dig Liver Dis 2011; 43: 881-886. D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006; 44: 217-231. Møller S, Henriksen JH, Bendtsen F. Ascites: pathogenesis and therapeutic principles. Scand J Gastroenterol 2009; 44: 902-911. Ginès P, Angeli P, Lenz K, Møller S, Moore K, Moreau R, et al. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 2010; 53: 397-417. Altman C, Bernard B, Roulot D, Vitte RL, Ink O. Randomized comparative multicenter study of hydroxyethyl starch versus albumin as a plasma expander in cirrhotic patients with tense ascites treated with paracentesis. Eur J Gastroenterol Hepatol 1998; 10: 5-10. Gentilini P, Casini-Raggi V, Di Fiore G, Romanelli RG, Buzzelli G, Pinzani M, et al. Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial. J Hepatol 1999; 30: 639-645. Runyon BA. Management of adult patients with ascites due to cirrhosis: an update. HEPATOLOGY 2009; 49: 2087-2107. Tønnessen T, Tølløfsrud S, Kongsgaard UE, Noddeland H. Colloid osmotic pressure of plasma replacement fluids. Acta Anaesthesiol Scand 1993; 37: 424-426. Jüni P, Altman DG, Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 2001; 323: 42-46. García-Compeán D, Villarreal JZ, Cuevas HB, Cantú DAG, Estrella M, Tamez EG, et al. Total therapeutic paracentesis (TTP) with and without intravenous albumin in the treatment of cirrhotic tense ascites: a randomized controlled trial. Liver 1993; 13: 233-238. Angeli P, Wong F, Watson H, Ginès P. Hyponatremia in cirrhosis: results of a patient population survey. HEPATOLOGY 2006; 44: 1535-1542. Wong CL, Holroyd-Leduc J, Thorpe KE, Straus SE. Does this patient have bacterial peritonitis or portal hypertension? How do I perform a paracentesis and analyze the results? JAMA 2008; 299: 1166-1178. Saló J, Ginès A, Ginès P, Piera C, Jiménez W, Guevara M, et al. Effect of therapeutic paracentesis on plasma volume and transvascular escape rate of albumin in patients with cirrhosis. J Hepatol 1997; 27: 645-653. Salerno F, Guevara M, Bernardi M, Moreau R, Wong F, Angeli P, et al. Refractory ascites: pathogenesis, definition, and therapy of a severe complication in patients with cirrhosis. Liver Int 2010; 30: 937-947. Ruiz-del-Arbol L, Monescillo A, Jiménez W, García-Plaza A, Arroyo V, Rodés J. Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis. Gastroenterology 1997; 113: 579-586. Ginès P, Berl T, Bernardi M, Bichet DG, Hamon G, Jiménez W, et al. Hyponatremia in cirrhosis: from pathogenesis to treatment. HEPATOLOGY 1998; 28: 851-864. Ginès P, Arroyo V, Quintero E, Planas R, Bory F, Cabrera J, et al. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study. Gastroenterology 1987; 93: 234-241. Ginès P, Cárdenas A. The management of ascites and hyponatremia in cirrhosis. Semin Liver Dis 2008; 28: 43-58. McCormick PA, Mistry P, Kaye G, Burroughs AK, McIntyre N. Intravenous albumin infusion is an effective therapy for hyponatraemia in cirrhotic patients with ascites. Gut 1990; 31: 204-207. Cárdenas A, Ginès P, Runyon BA. Is albumin infusion necessary after large volume paracentesis? Liver Int 2009; 29: 636-640. Fassio E, Terg R, Landeira G, Abecasis R, Salemne M, Podesta A, et al. Paracentesis with dextran 70 vs. paracentesis with albumin in cirrhosis with tense ascites. Results of a randomized study. J Hepatol 1992; 14: 310-316. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634. Moore KP, Aithal GP. Guidelines on the management of ascites in cirrhosis. Gut 2006; 55( Suppl 6): 1-12. Vila MC, Solà R, Molina L, Andreu M, Coll S, Gana J, et al. Hemodynamic changes in patients developing effective hypovolemia after total paracentesis. J Hepatol 1998; 28: 639-645. García-Compeán D, Blanc P, Larrey D, Daures JP, Hirtz J, Mendoza E, et al. Treatment of cirrhotic tense ascites with Dextran-40 versus albumin associated with large volume paracentesis: a randomized controlled trial. Ann Hepatol 2002; 1: 29-35. Moreau R, Asselah T, Condat B, de Kerguenec C, Pessione F, Bernard B, et al. Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study. Gut 2002; 50: 90-94. Guevara M, Baccaro ME, Ríos J, Martín-Llahí M, Uriz J, Ruiz del Arbol L, et al. Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration. Liver Int 2010; 30: 1137-1142. Quintero E, Ginès P, Arroyo V, Rimola A, Bory F, Planas R, et al. Paracentesis versus diuretics in the treatment of cirrhotics with tense ascites. Lancet 1985; 1: 611-612. Planas R, Ginès P, Arroyo V, Llach J, Panés J, Vargas V, et al. Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Results of a randomized study. Gastroenterology 1990; 99: 1736-1744. Singh V, Kumar B, Nain CK, Singh B, Sharma N, Bhalla A, Sharma AK. Noradrenaline and albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized pilot study. J Intern Med 2006; 260: 62-68. Sola-Vera J, Miñana J, Ricart E, Planella M, González B, Torras X, et al. Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites. HEPATOLOGY 2003; 37: 1147-1153. Moreau R, Valla DC, Durand-Zaleski I, Bronowicki JP, Durand F, Chaput JC, et al. Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid: a randomised controlled pilot trail. Liver Int 2006; 26: 46-54. Salerno F, Badalamenti S, Lorenzano E, Moser P, Incerti P. Randomized comparative study of hemaccel vs. albumin infusion after total paracentesis in cirrhotic patients with refractory ascites. HEPATOLOGY 1991; 13: 707-713. Singh V, Kumar R, Nain CK, Singh B, Sharma AK. Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study. J Gastroenterol Hepatol 2006; 21: 303-307. Ginès P, Titó L, Arroyo V, Planas R, Panés J, Viver J, et al. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology 1988; 94: 1493-1502. 1997; 113 2009; 44 2010; 11 1990; 31 2010; 53 1998; 28 1985; 1 1997; 315 1990; 99 1987; 93 2006; 12 1991; 13 2002; 50 2006; 55 2002; 1 2005; 41 2003; 37 2005; 42 1997; 27 1988; 94 1992; 14 2008; 103 2009; 49 2001; 323 2009; 29 1993; 37 1993; 13 2006; 21 2009; 50 2006; 44 1995; 22 2008; 28 2006; 26 2011; 43 2008; 359 1996; 111 1999; 31 1999; 30 2006; 260 2008; 299 1998; 10 2010; 30 2007; 46 DAmico (R1-21-20241201) 2006; 44 Schindler (R47-21-20241201) 1999; 31 Gines (R13-21-20241201) 2008; 28 Arroyo (R45-21-20241201) 2009; 50 Salerno (R18-21-20241201) 1991; 13 SolaVera (R26-21-20241201) 2003; 37 Moore (R4-21-20241201) 2006; 55 Alessandria (R35-21-20241201) 2011; 43 Salerno (R14-21-20241201) 2010; 30 Cardenas (R42-21-20241201) 2009; 29 Planas (R17-21-20241201) 1990; 99 Singh (R28-21-20241201) 2006; 260 Tnnessen (R33-21-20241201) 1993; 37 Quinlan (R43-21-20241201) 2005; 41 Salo (R11-21-20241201) 1997; 27 RuizdelArbol (R10-21-20241201) 1997; 113 Vila (R9-21-20241201) 1998; 28 AbdelKhalek (R32-21-20241201) 2010; 11 Jalan (R41-21-20241201) 2007; 46 Juni (R16-21-20241201) 2001; 323 Luca (R21-21-20241201) 1995; 22 Gines (R6-21-20241201) 2010; 53 Quintero (R7-21-20241201) 1985; 1 Runyon (R5-21-20241201) 2009; 49 Jalan (R44-21-20241201) 2009; 50 Moreau (R27-21-20241201) 2006; 26 McCormick (R40-21-20241201) 1990; 31 Gentilini (R46-21-20241201) 1999; 30 Guevara (R38-21-20241201) 2010; 30 Kim (R37-21-20241201) 2008; 359 Gines (R2-21-20241201) 1988; 94 Moreau (R25-21-20241201) 2002; 50 Singh (R29-21-20241201) 2006; 21 Fernandez (R34-21-20241201) 2005; 42 Fassio (R19-21-20241201) 1992; 14 Romanelli (R48-21-20241201) 2006; 12 GarciaCompean (R24-21-20241201) 2002; 1 Singh (R31-21-20241201) 2008; 103 Gines (R8-21-20241201) 1987; 93 Gines (R36-21-20241201) 1998; 28 Mller (R12-21-20241201) 2009; 44 Wong (R49-21-20241201) 2008; 299 Angeli (R39-21-20241201) 2006; 44 Egger (R15-21-20241201) 1997; 315 Gines (R22-21-20241201) 1996; 111 GarciaCompean (R20-21-20241201) 1993; 13 Altman (R23-21-20241201) 1998; 10 Appenrodt (R30-21-20241201) 2008; 28 Cholongitas (R3-21-20241201) 2006; 21 24585539 - Hepatology. 2014 Oct;60(4):1443-5 24585570 - Hepatology. 2014 Oct;60(4):1442-3 |
| References_xml | – reference: Salerno F, Guevara M, Bernardi M, Moreau R, Wong F, Angeli P, et al. Refractory ascites: pathogenesis, definition, and therapy of a severe complication in patients with cirrhosis. Liver Int 2010; 30: 937-947. – reference: Planas R, Ginès P, Arroyo V, Llach J, Panés J, Vargas V, et al. Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Results of a randomized study. Gastroenterology 1990; 99: 1736-1744. – reference: Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634. – reference: Arroyo V. Human serum albumin: not just a plasma volume expander. HEPATOLOGY 2009; 50: 355-357. – reference: Alessandria C, Elia C, Mezzabotta L, Risso A, Andrealli A, Spandre M, et al. Prevention of paracentesis-induced circulatory dysfunction in cirrhosis: standard vs half albumin doses. A prospective, randomized, unblinded pilot study. Dig Liver Dis 2011; 43: 881-886. – reference: Romanelli RG, La Villa G, Barletta G, Vizzutti F, Lanini F, Arena U, et al. Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial. World J Gastroenterol 2006; 12: 1403-1407. – reference: Ginès P, Arroyo V, Quintero E, Planas R, Bory F, Cabrera J, et al. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study. Gastroenterology 1987; 93: 234-241. – reference: Ginès P, Cárdenas A. The management of ascites and hyponatremia in cirrhosis. Semin Liver Dis 2008; 28: 43-58. – reference: García-Compeán D, Villarreal JZ, Cuevas HB, Cantú DAG, Estrella M, Tamez EG, et al. Total therapeutic paracentesis (TTP) with and without intravenous albumin in the treatment of cirrhotic tense ascites: a randomized controlled trial. Liver 1993; 13: 233-238. – reference: Angeli P, Wong F, Watson H, Ginès P. Hyponatremia in cirrhosis: results of a patient population survey. HEPATOLOGY 2006; 44: 1535-1542. – reference: Abdel-Khalek EE, Arif SE. Randomized trial comparing human albumin and hydroxyethyl starch 6% as plasma expanders for treatment of patients with liver cirrhosis and tense ascites following large volume paracentesis. Arab J Gastroenterol 2010; 11: 24-29. – reference: Appenrodt B, Wolf A, Grunhage F, Trebicka J, Schepke M, Rabe C, et al. Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study. Liver Int 2008; 28: 1019-1025. – reference: Ginès A, Fernández-Esparrach G, Monescillo A, Vila C, Domènech E, Abecasis R, et al. Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology 1996; 111: 1002-1010. – reference: McCormick PA, Mistry P, Kaye G, Burroughs AK, McIntyre N. Intravenous albumin infusion is an effective therapy for hyponatraemia in cirrhotic patients with ascites. Gut 1990; 31: 204-207. – reference: Moreau R, Asselah T, Condat B, de Kerguenec C, Pessione F, Bernard B, et al. Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study. Gut 2002; 50: 90-94. – reference: Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008; 359: 1018-1026. – reference: Sola-Vera J, Miñana J, Ricart E, Planella M, González B, Torras X, et al. Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites. HEPATOLOGY 2003; 37: 1147-1153. – reference: Fassio E, Terg R, Landeira G, Abecasis R, Salemne M, Podesta A, et al. Paracentesis with dextran 70 vs. paracentesis with albumin in cirrhosis with tense ascites. Results of a randomized study. J Hepatol 1992; 14: 310-316. – reference: Salerno F, Badalamenti S, Lorenzano E, Moser P, Incerti P. Randomized comparative study of hemaccel vs. albumin infusion after total paracentesis in cirrhotic patients with refractory ascites. HEPATOLOGY 1991; 13: 707-713. – reference: Ginès P, Berl T, Bernardi M, Bichet DG, Hamon G, Jiménez W, et al. Hyponatremia in cirrhosis: from pathogenesis to treatment. HEPATOLOGY 1998; 28: 851-864. – reference: García-Compeán D, Blanc P, Larrey D, Daures JP, Hirtz J, Mendoza E, et al. Treatment of cirrhotic tense ascites with Dextran-40 versus albumin associated with large volume paracentesis: a randomized controlled trial. Ann Hepatol 2002; 1: 29-35. – reference: Cárdenas A, Ginès P, Runyon BA. Is albumin infusion necessary after large volume paracentesis? Liver Int 2009; 29: 636-640. – reference: Luca A, García-Pagán JC, Bosch J, Feu F, Jiménez W, Ginès A, et al. Beneficial effects of intravenous albumin infusion on the hemodynamic and humoral changes after total paracentesis. HEPATOLOGY 1995; 22: 753-758. – reference: Ginès P, Angeli P, Lenz K, Møller S, Moore K, Moreau R, et al. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 2010; 53: 397-417. – reference: Singh V, Kumar B, Nain CK, Singh B, Sharma N, Bhalla A, Sharma AK. Noradrenaline and albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized pilot study. J Intern Med 2006; 260: 62-68. – reference: Singh V, Kumar R, Nain CK, Singh B, Sharma AK. Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study. J Gastroenterol Hepatol 2006; 21: 303-307. – reference: Quinlan GJ, Martin GS, Evans TW. Albumin: biochemical properties and therapeutic potential. HEPATOLOGY 2005; 41: 1211-1219. – reference: Altman C, Bernard B, Roulot D, Vitte RL, Ink O. Randomized comparative multicenter study of hydroxyethyl starch versus albumin as a plasma expander in cirrhotic patients with tense ascites treated with paracentesis. Eur J Gastroenterol Hepatol 1998; 10: 5-10. – reference: Gentilini P, Casini-Raggi V, Di Fiore G, Romanelli RG, Buzzelli G, Pinzani M, et al. Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial. J Hepatol 1999; 30: 639-645. – reference: Singh V, Dheerendra PC, Singh B, Nain CK, Chawla D, Sharma N, et al. Midodrine versus albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotics: a randomized pilot study. Am J Gastroenterol 2008; 103: 1399-1405. – reference: Runyon BA. Management of adult patients with ascites due to cirrhosis: an update. HEPATOLOGY 2009; 49: 2087-2107. – reference: Vila MC, Solà R, Molina L, Andreu M, Coll S, Gana J, et al. Hemodynamic changes in patients developing effective hypovolemia after total paracentesis. J Hepatol 1998; 28: 639-645. – reference: Jalan R, Mookerjee RP, Cheshire LM, Williams R, Davies NA. Albumin infusion for severe hyponatremia in patients with refractory ascites: a randomized clinical trial. J Hepatol 2007; 46: S95. – reference: Jüni P, Altman DG, Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 2001; 323: 42-46. – reference: D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006; 44: 217-231. – reference: Ginès P, Titó L, Arroyo V, Planas R, Panés J, Viver J, et al. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology 1988; 94: 1493-1502. – reference: Quintero E, Ginès P, Arroyo V, Rimola A, Bory F, Planas R, et al. Paracentesis versus diuretics in the treatment of cirrhotics with tense ascites. Lancet 1985; 1: 611-612. – reference: Schindler C, Ramadori G. Albumin substitution improves urinary sodium excretion and diuresis in patients with liver cirrhosis and refractory ascites. J Hepatol 1999; 31: 1132. – reference: Saló J, Ginès A, Ginès P, Piera C, Jiménez W, Guevara M, et al. Effect of therapeutic paracentesis on plasma volume and transvascular escape rate of albumin in patients with cirrhosis. J Hepatol 1997; 27: 645-653. – reference: Moore KP, Aithal GP. Guidelines on the management of ascites in cirrhosis. Gut 2006; 55( Suppl 6): 1-12. – reference: Jalan R, Schnurr K, Mookerjee RP, Sen S, Cheshire L, Hodges S, et al. Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality. HEPATOLOGY 2009; 50: 555-564. – reference: Moreau R, Valla DC, Durand-Zaleski I, Bronowicki JP, Durand F, Chaput JC, et al. Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid: a randomised controlled pilot trail. Liver Int 2006; 26: 46-54. – reference: Møller S, Henriksen JH, Bendtsen F. Ascites: pathogenesis and therapeutic principles. Scand J Gastroenterol 2009; 44: 902-911. – reference: Ruiz-del-Arbol L, Monescillo A, Jiménez W, García-Plaza A, Arroyo V, Rodés J. Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis. Gastroenterology 1997; 113: 579-586. – reference: Fernández J, Monteagudo J, Bargallo X, Jiménez W, Bosch J, Arroyo V, Navasa M. A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis. HEPATOLOGY 2005; 42: 627-634. – reference: Wong CL, Holroyd-Leduc J, Thorpe KE, Straus SE. Does this patient have bacterial peritonitis or portal hypertension? How do I perform a paracentesis and analyze the results? JAMA 2008; 299: 1166-1178. – reference: Cholongitas E, Papatheodoridis GV, Manesis EK, Burroughs AK, Archimandritis AJ. Spontaneous bacterial peritonitis in cirrhotic patients: is prophylactic propranolol therapy beneficial? J Gastroenterol Hepatol 2006; 21: 581-587. – reference: Tønnessen T, Tølløfsrud S, Kongsgaard UE, Noddeland H. Colloid osmotic pressure of plasma replacement fluids. Acta Anaesthesiol Scand 1993; 37: 424-426. – reference: Guevara M, Baccaro ME, Ríos J, Martín-Llahí M, Uriz J, Ruiz del Arbol L, et al. Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration. Liver Int 2010; 30: 1137-1142. – volume: 21 start-page: 303 year: 2006 end-page: 307 article-title: Terlipressin versus albumin in paracentesis‐induced circulatory dysfunction in cirrhosis: a randomized study publication-title: J Gastroenterol Hepatol – volume: 14 start-page: 310 year: 1992 end-page: 316 article-title: Paracentesis with dextran 70 vs. paracentesis with albumin in cirrhosis with tense ascites. Results of a randomized study publication-title: J Hepatol – volume: 99 start-page: 1736 year: 1990 end-page: 1744 article-title: Dextran‐70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Results of a randomized study publication-title: Gastroenterology – volume: 50 start-page: 555 year: 2009 end-page: 564 article-title: Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality publication-title: HEPATOLOGY – volume: 323 start-page: 42 year: 2001 end-page: 46 article-title: Systematic reviews in health care: assessing the quality of controlled clinical trials publication-title: BMJ – volume: 28 start-page: 1019 year: 2008 end-page: 1025 article-title: Prevention of paracentesis‐induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study publication-title: Liver Int – volume: 30 start-page: 937 year: 2010 end-page: 947 article-title: Refractory ascites: pathogenesis, definition, and therapy of a severe complication in patients with cirrhosis publication-title: Liver Int – volume: 11 start-page: 24 year: 2010 end-page: 29 article-title: Randomized trial comparing human albumin and hydroxyethyl starch 6% as plasma expanders for treatment of patients with liver cirrhosis and tense ascites following large volume paracentesis publication-title: Arab J Gastroenterol – volume: 27 start-page: 645 year: 1997 end-page: 653 article-title: Effect of therapeutic paracentesis on plasma volume and transvascular escape rate of albumin in patients with cirrhosis publication-title: J Hepatol – volume: 44 start-page: 902 year: 2009 end-page: 911 article-title: Ascites: pathogenesis and therapeutic principles publication-title: Scand J Gastroenterol – volume: 42 start-page: 627 year: 2005 end-page: 634 article-title: A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis publication-title: HEPATOLOGY – volume: 260 start-page: 62 year: 2006 end-page: 68 article-title: Noradrenaline and albumin in paracentesis‐induced circulatory dysfunction in cirrhosis: a randomized pilot study publication-title: J Intern Med – volume: 103 start-page: 1399 year: 2008 end-page: 1405 article-title: Midodrine versus albumin in the prevention of paracentesis‐induced circulatory dysfunction in cirrhotics: a randomized pilot study publication-title: Am J Gastroenterol – volume: 30 start-page: 639 year: 1999 end-page: 645 article-title: Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial publication-title: J Hepatol – volume: 21 start-page: 581 year: 2006 end-page: 587 article-title: Spontaneous bacterial peritonitis in cirrhotic patients: is prophylactic propranolol therapy beneficial? publication-title: J Gastroenterol Hepatol – volume: 53 start-page: 397 year: 2010 end-page: 417 article-title: EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis publication-title: J Hepatol – volume: 29 start-page: 636 year: 2009 end-page: 640 article-title: Is albumin infusion necessary after large volume paracentesis? publication-title: Liver Int – volume: 28 start-page: 851 year: 1998 end-page: 864 article-title: Hyponatremia in cirrhosis: from pathogenesis to treatment publication-title: HEPATOLOGY – volume: 28 start-page: 43 year: 2008 end-page: 58 article-title: The management of ascites and hyponatremia in cirrhosis publication-title: Semin Liver Dis – volume: 30 start-page: 1137 year: 2010 end-page: 1142 article-title: Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration publication-title: Liver Int – volume: 50 start-page: 355 year: 2009 end-page: 357 article-title: Human serum albumin: not just a plasma volume expander publication-title: HEPATOLOGY – volume: 1 start-page: 611 year: 1985 end-page: 612 article-title: Paracentesis versus diuretics in the treatment of cirrhotics with tense ascites publication-title: Lancet – volume: 1 start-page: 29 year: 2002 end-page: 35 article-title: Treatment of cirrhotic tense ascites with Dextran‐40 versus albumin associated with large volume paracentesis: a randomized controlled trial publication-title: Ann Hepatol – volume: 44 start-page: 217 year: 2006 end-page: 231 article-title: Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies publication-title: J Hepatol – volume: 111 start-page: 1002 year: 1996 end-page: 1010 article-title: Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis publication-title: Gastroenterology – volume: 315 start-page: 629 year: 1997 end-page: 634 article-title: Bias in meta‐analysis detected by a simple, graphical test publication-title: BMJ – volume: 22 start-page: 753 year: 1995 end-page: 758 article-title: Beneficial effects of intravenous albumin infusion on the hemodynamic and humoral changes after total paracentesis publication-title: HEPATOLOGY – volume: 359 start-page: 1018 year: 2008 end-page: 1026 article-title: Hyponatremia and mortality among patients on the liver‐transplant waiting list publication-title: N Engl J Med – volume: 12 start-page: 1403 year: 2006 end-page: 1407 article-title: Long‐term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial publication-title: World J Gastroenterol – volume: 94 start-page: 1493 year: 1988 end-page: 1502 article-title: Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis publication-title: Gastroenterology – volume: 13 start-page: 233 year: 1993 end-page: 238 article-title: Total therapeutic paracentesis (TTP) with and without intravenous albumin in the treatment of cirrhotic tense ascites: a randomized controlled trial publication-title: Liver – volume: 50 start-page: 90 year: 2002 end-page: 94 article-title: Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study publication-title: Gut – volume: 28 start-page: 639 year: 1998 end-page: 645 article-title: Hemodynamic changes in patients developing effective hypovolemia after total paracentesis publication-title: J Hepatol – volume: 46 start-page: S95 year: 2007 article-title: Albumin infusion for severe hyponatremia in patients with refractory ascites: a randomized clinical trial publication-title: J Hepatol – volume: 49 start-page: 2087 year: 2009 end-page: 2107 article-title: Management of adult patients with ascites due to cirrhosis: an update publication-title: HEPATOLOGY – volume: 43 start-page: 881 year: 2011 end-page: 886 article-title: Prevention of paracentesis‐induced circulatory dysfunction in cirrhosis: standard vs half albumin doses. A prospective, randomized, unblinded pilot study publication-title: Dig Liver Dis – volume: 37 start-page: 1147 year: 2003 end-page: 1153 article-title: Randomized trial comparing albumin and saline in the prevention of paracentesis‐induced circulatory dysfunction in cirrhotic patients with ascites publication-title: HEPATOLOGY – volume: 113 start-page: 579 year: 1997 end-page: 586 article-title: Paracentesis‐induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis publication-title: Gastroenterology – volume: 44 start-page: 1535 year: 2006 end-page: 1542 article-title: Hyponatremia in cirrhosis: results of a patient population survey publication-title: HEPATOLOGY – volume: 31 start-page: 1132 year: 1999 article-title: Albumin substitution improves urinary sodium excretion and diuresis in patients with liver cirrhosis and refractory ascites publication-title: J Hepatol – volume: 93 start-page: 234 year: 1987 end-page: 241 article-title: Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study publication-title: Gastroenterology – volume: 13 start-page: 707 year: 1991 end-page: 713 article-title: Randomized comparative study of hemaccel vs. albumin infusion after total paracentesis in cirrhotic patients with refractory ascites publication-title: HEPATOLOGY – volume: 41 start-page: 1211 year: 2005 end-page: 1219 article-title: Albumin: biochemical properties and therapeutic potential publication-title: HEPATOLOGY – volume: 55 start-page: 1 issue: Suppl 6 year: 2006 end-page: 12 article-title: Guidelines on the management of ascites in cirrhosis publication-title: Gut – volume: 37 start-page: 424 year: 1993 end-page: 426 article-title: Colloid osmotic pressure of plasma replacement fluids publication-title: Acta Anaesthesiol Scand – volume: 299 start-page: 1166 year: 2008 end-page: 1178 article-title: Does this patient have bacterial peritonitis or portal hypertension? How do I perform a paracentesis and analyze the results? publication-title: JAMA – volume: 10 start-page: 5 year: 1998 end-page: 10 article-title: Randomized comparative multicenter study of hydroxyethyl starch versus albumin as a plasma expander in cirrhotic patients with tense ascites treated with paracentesis publication-title: Eur J Gastroenterol Hepatol – volume: 26 start-page: 46 year: 2006 end-page: 54 article-title: Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid: a randomised controlled pilot trail publication-title: Liver Int – volume: 31 start-page: 204 year: 1990 end-page: 207 article-title: Intravenous albumin infusion is an effective therapy for hyponatraemia in cirrhotic patients with ascites publication-title: Gut – volume: 323 start-page: 42 year: 2001 ident: R16-21-20241201 article-title: Systematic reviews in health care: assessing the quality of controlled clinical trials. publication-title: BMJ doi: 10.1136/bmj.323.7303.42 – volume: 22 start-page: 753 year: 1995 ident: R21-21-20241201 article-title: Beneficial effects of intravenous albumin infusion on the hemodynamic and humoral changes after total paracentesis. publication-title: HEPATOLOGY – volume: 28 start-page: 851 year: 1998 ident: R36-21-20241201 article-title: Hyponatremia in cirrhosis: from pathogenesis to treatment. publication-title: HEPATOLOGY doi: 10.1002/hep.510280337 – volume: 111 start-page: 1002 year: 1996 ident: R22-21-20241201 article-title: Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. publication-title: Gastroenterology doi: 10.1016/S0016-5085(96)70068-9 – volume: 44 start-page: 217 year: 2006 ident: R1-21-20241201 article-title: Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. publication-title: J Hepatol doi: 10.1016/j.jhep.2005.10.013 – volume: 43 start-page: 881 year: 2011 ident: R35-21-20241201 article-title: Prevention of paracentesisinduced circulatory dysfunction in cirrhosis: standard vs half albumin doses. A prospective, randomized, unblinded pilot study. publication-title: Dig Liver Dis – volume: 29 start-page: 636 year: 2009 ident: R42-21-20241201 article-title: Is albumin infusion necessary after large volume paracentesis? publication-title: Liver Int doi: 10.1111/j.1478-3231.2009.02027_1.x – volume: 50 start-page: 355 year: 2009 ident: R45-21-20241201 article-title: Human serum albumin: not just a plasma volume expander. publication-title: HEPATOLOGY doi: 10.1002/hep.23006 – volume: 11 start-page: 24 year: 2010 ident: R32-21-20241201 article-title: Randomized trial comparing human albumin and hydroxyethyl starch 6 as plasma expanders for treatment of patients with liver cirrhosis and tense ascites following large volume paracentesis. publication-title: Arab J Gastroenterol doi: 10.1016/j.ajg.2010.01.006 – volume: 113 start-page: 579 year: 1997 ident: R10-21-20241201 article-title: Paracentesisinduced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis. publication-title: Gastroenterology doi: 10.1053/gast.1997.v113.pm9247479 – volume: 28 start-page: 1019 year: 2008 ident: R30-21-20241201 article-title: Prevention of paracentesisinduced circulatory dysfunction: midodrine vs albumin. A randomized pilot study. publication-title: Liver Int doi: 10.1111/j.1478-3231.2008.01734.x – volume: 41 start-page: 1211 year: 2005 ident: R43-21-20241201 article-title: Albumin: biochemical properties and therapeutic potential. publication-title: HEPATOLOGY doi: 10.1002/hep.20720 – volume: 99 start-page: 1736 year: 1990 ident: R17-21-20241201 article-title: Dextran70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Results of a randomized study. publication-title: Gastroenterology doi: 10.1016/0016-5085(90)90481-F – volume: 103 start-page: 1399 year: 2008 ident: R31-21-20241201 article-title: Midodrine versus albumin in the prevention of paracentesisinduced circulatory dysfunction in cirrhotics: a randomized pilot study. publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.2008.01787.x – volume: 46 start-page: S95 year: 2007 ident: R41-21-20241201 article-title: Albumin infusion for severe hyponatremia in patients with refractory ascites: a randomized clinical trial. publication-title: J Hepatol doi: 10.1016/S0168-8278(07)61830-3 – volume: 13 start-page: 707 year: 1991 ident: R18-21-20241201 article-title: Randomized comparative study of hemaccel vs. albumin infusion after total paracentesis in cirrhotic patients with refractory ascites. publication-title: HEPATOLOGY doi: 10.1002/hep.1840130416 – volume: 50 start-page: 555 year: 2009 ident: R44-21-20241201 article-title: Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality. publication-title: HEPATOLOGY doi: 10.1002/hep.22913 – volume: 260 start-page: 62 year: 2006 ident: R28-21-20241201 article-title: Noradrenaline and albumin in paracentesisinduced circulatory dysfunction in cirrhosis: a randomized pilot study. publication-title: J Intern Med doi: 10.1111/j.1365-2796.2006.01654.x – volume: 30 start-page: 937 year: 2010 ident: R14-21-20241201 article-title: Refractory ascites: pathogenesis, definition, and therapy of a severe complication in patients with cirrhosis. publication-title: Liver Int doi: 10.1111/j.1478-3231.2010.02272.x – volume: 37 start-page: 1147 year: 2003 ident: R26-21-20241201 article-title: Randomized trial comparing albumin and saline in the prevention of paracentesisinduced circulatory dysfunction in cirrhotic patients with ascites. publication-title: HEPATOLOGY doi: 10.1053/jhep.2003.50169 – volume: 30 start-page: 639 year: 1999 ident: R46-21-20241201 article-title: Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial. publication-title: J Hepatol doi: 10.1016/S0168-8278(99)80194-9 – volume: 44 start-page: 1535 year: 2006 ident: R39-21-20241201 article-title: Hyponatremia in cirrhosis: results of a patient population survey. publication-title: HEPATOLOGY doi: 10.1002/hep.21412 – volume: 21 start-page: 303 year: 2006 ident: R29-21-20241201 article-title: Terlipressin versus albumin in paracentesisinduced circulatory dysfunction in cirrhosis: a randomized study. publication-title: J Gastroenterol Hepatol doi: 10.1111/j.1440-1746.2006.04182.x – volume: 55 start-page: 1 issue: Suppl 6 year: 2006 ident: R4-21-20241201 article-title: Guidelines on the management of ascites in cirrhosis. publication-title: Gut – volume: 26 start-page: 46 year: 2006 ident: R27-21-20241201 article-title: Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid: a randomised controlled pilot trail. publication-title: Liver Int doi: 10.1111/j.1478-3231.2005.01188.x – volume: 27 start-page: 645 year: 1997 ident: R11-21-20241201 article-title: Effect of therapeutic paracentesis on plasma volume and transvascular escape rate of albumin in patients with cirrhosis. publication-title: J Hepatol doi: 10.1016/S0168-8278(97)80081-5 – volume: 94 start-page: 1493 year: 1988 ident: R2-21-20241201 article-title: Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. publication-title: Gastroenterology doi: 10.1016/0016-5085(88)90691-9 – volume: 44 start-page: 902 year: 2009 ident: R12-21-20241201 article-title: Ascites: pathogenesis and therapeutic principles. publication-title: Scand J Gastroenterol doi: 10.1080/00365520902912555 – volume: 315 start-page: 629 year: 1997 ident: R15-21-20241201 article-title: Bias in metaanalysis detected by a simple, graphical test. publication-title: BMJ doi: 10.1136/bmj.315.7109.629 – volume: 49 start-page: 2087 year: 2009 ident: R5-21-20241201 article-title: Management of adult patients with ascites due to cirrhosis: an update. publication-title: HEPATOLOGY doi: 10.1002/hep.22853 – volume: 50 start-page: 90 year: 2002 ident: R25-21-20241201 article-title: Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study. publication-title: Gut doi: 10.1136/gut.50.1.90 – volume: 1 start-page: 611 year: 1985 ident: R7-21-20241201 article-title: Paracentesis versus diuretics in the treatment of cirrhotics with tense ascites. publication-title: Lancet doi: 10.1016/S0140-6736(85)92147-6 – volume: 37 start-page: 424 year: 1993 ident: R33-21-20241201 article-title: Colloid osmotic pressure of plasma replacement fluids. publication-title: Acta Anaesthesiol Scand doi: 10.1111/j.1399-6576.1993.tb03741.x – volume: 1 start-page: 29 year: 2002 ident: R24-21-20241201 article-title: Treatment of cirrhotic tense ascites with Dextran40 versus albumin associated with large volume paracentesis: a randomized controlled trial. publication-title: Ann Hepatol doi: 10.1016/S1665-2681(19)32189-1 – volume: 14 start-page: 310 year: 1992 ident: R19-21-20241201 article-title: Paracentesis with dextran 70 vs. paracentesis with albumin in cirrhosis with tense ascites. Results of a randomized study. publication-title: J Hepatol doi: 10.1016/0168-8278(92)90176-P – volume: 31 start-page: 1132 year: 1999 ident: R47-21-20241201 article-title: Albumin substitution improves urinary sodium excretion and diuresis in patients with liver cirrhosis and refractory ascites. publication-title: J Hepatol doi: 10.1016/S0168-8278(99)80329-8 – volume: 10 start-page: 5 year: 1998 ident: R23-21-20241201 article-title: Randomized comparative multicenter study of hydroxyethyl starch versus albumin as a plasma expander in cirrhotic patients with tense ascites treated with paracentesis. publication-title: Eur J Gastroenterol Hepatol doi: 10.1097/00042737-199801000-00002 – volume: 21 start-page: 581 year: 2006 ident: R3-21-20241201 article-title: Spontaneous bacterial peritonitis in cirrhotic patients: is prophylactic propranolol therapy beneficial? publication-title: J Gastroenterol Hepatol doi: 10.1111/j.1440-1746.2005.03982.x – volume: 42 start-page: 627 year: 2005 ident: R34-21-20241201 article-title: A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis. publication-title: HEPATOLOGY doi: 10.1002/hep.20829 – volume: 28 start-page: 43 year: 2008 ident: R13-21-20241201 article-title: The management of ascites and hyponatremia in cirrhosis. publication-title: Semin Liver Dis doi: 10.1055/s-2008-1040320 – volume: 359 start-page: 1018 year: 2008 ident: R37-21-20241201 article-title: Hyponatremia and mortality among patients on the livertransplant waiting list. publication-title: N Engl J Med doi: 10.1056/NEJMoa0801209 – volume: 28 start-page: 639 year: 1998 ident: R9-21-20241201 article-title: Hemodynamic changes in patients developing effective hypovolemia after total paracentesis. publication-title: J Hepatol doi: 10.1016/S0168-8278(98)80288-2 – volume: 13 start-page: 233 year: 1993 ident: R20-21-20241201 article-title: Total therapeutic paracentesis (TTP) with and without intravenous albumin in the treatment of cirrhotic tense ascites: a randomized controlled trial. publication-title: Liver doi: 10.1111/j.1600-0676.1993.tb00637.x – volume: 299 start-page: 1166 year: 2008 ident: R49-21-20241201 article-title: Does this patient have bacterial peritonitis or portal hypertension? How do I perform a paracentesis and analyze the results? publication-title: JAMA doi: 10.1001/jama.299.10.1166 – volume: 53 start-page: 397 year: 2010 ident: R6-21-20241201 article-title: EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. publication-title: J Hepatol doi: 10.1016/j.jhep.2010.05.004 – volume: 31 start-page: 204 year: 1990 ident: R40-21-20241201 article-title: Intravenous albumin infusion is an effective therapy for hyponatraemia in cirrhotic patients with ascites. publication-title: Gut doi: 10.1136/gut.31.2.204 – volume: 93 start-page: 234 year: 1987 ident: R8-21-20241201 article-title: Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study. publication-title: Gastroenterology doi: 10.1016/0016-5085(87)91007-9 – volume: 12 start-page: 1403 year: 2006 ident: R48-21-20241201 article-title: Longterm albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial. publication-title: World J Gastroenterol doi: 10.3748/wjg.v12.i9.1403 – volume: 30 start-page: 1137 year: 2010 ident: R38-21-20241201 article-title: Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration. publication-title: Liver Int doi: 10.1111/j.1478-3231.2010.02293.x – reference: 24585539 - Hepatology. 2014 Oct;60(4):1443-5 – reference: 24585570 - Hepatology. 2014 Oct;60(4):1442-3 |
| SSID | ssj0009428 |
| Score | 2.514781 |
| SecondaryResourceType | review_article |
| Snippet | Albumin infusion reduces the incidence of postparacentesis circulatory dysfunction among patients with cirrhosis and tense ascites, as compared with no... |
| SourceID | proquest pubmed pascalfrancis crossref wiley istex |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1172 |
| SubjectTerms | Albumins - administration & dosage Albumins - therapeutic use Ascites - etiology Ascites - mortality Ascites - therapy Biological and medical sciences Confidence intervals Female Gastroenterology. Liver. Pancreas. Abdomen Humans Hyponatremia - epidemiology Hyponatremia - prevention & control Incidence Infusions, Intravenous Liver cirrhosis Liver Cirrhosis - complications Liver. Biliary tract. Portal circulation. Exocrine pancreas Male Medical sciences Meta-analysis Middle Aged Mortality Paracentesis - methods Randomized Controlled Trials as Topic Survival Rate |
| Title | Albumin infusion in patients undergoing large-volume paracentesis: A meta-analysis of randomized trials |
| URI | https://api.istex.fr/ark:/67375/WNG-SLDRZ9T3-6/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fhep.24786 https://www.ncbi.nlm.nih.gov/pubmed/22095893 https://www.proquest.com/docview/1748112434 https://www.proquest.com/docview/1753459923 https://www.proquest.com/docview/963489075 |
| Volume | 55 |
| WOSCitedRecordID | wos000302069900021&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library Full Collection 2020 customDbUrl: eissn: 1527-3350 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0009428 issn: 0270-9139 databaseCode: DRFUL dateStart: 19960101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1fb9MwED9tLUK88B8WGJVBCPGSLXHixIania3soVTT2ETFS-TENqu2JVPTIsQTH4HPyCfh7KSpKm0SEm-WfFbk8935F_v8O4DXqaA5K5LEpyYs_FiY0Oc60AjkIqWUyRVXrmrJKB2P-WQijjbg_fItTMMP0R24Wc9w8do6uMzr3RVp6Jm-2qFxypNN6FO0W9aD_v7x8HS04tyNXWlV_PEK7AWzWBILBXS3G7y2HfWtZn_Y9EhZo4ZMU9riOuy5DmXdXjS891-zuA93WwhK9hqbeQAbunwItz-1l-yP4Nwd209Lgsa3sIdp2CAt_2pN7KOz2bcKdzxyYbPI__z63UQ4YlnEba6nrqf1O7JHLvVcYq9saU9IZQhOVVWX059aEVcupH4Mp8ODkw-HfluTwS9sPpuv8tRoSQNpIq1EKHkiqExzZoRiIqS5MCyVmuUmkjyMuFGxDDlKG8c5mrPoCfTKqtRbQDS1ASB2BP0xAhupEioUR8iVKpYI7sHb5dJkRUtYbutmXGQN1TLNUHmZU54HrzrRq4al4zqhN259Owk5O7dpbSnLvow_Zp9H-8dfxUmUoeBgzQC6AZTxwCbzebC9tIisdfk6w187juA1jmIPXnbd6Kz2BkaWulpYGRbFTCCo9oDcIIMRMeYCkZwHTxtjW32fIiBGgImacTZ181yzw4Mj13j276LP4Q6iQdqkJW1Dbz5b6Bdwq_g-n9azAWymEz5oXewv6TsqRA |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NbhMxEB6VBgEX_n8WSjEIIS5Ls15710ZcKtoQRBpVJVUrLpY3tiFqm1TZBCFOPALPyJMw9m42itRKSNwseayVxzPjb-3xNwAvc0kLPsyymLpkGDPpkljYtkUglxpjXGGECVVLenm_L46P5f4avFu8han4IZoDN-8ZIV57B_cH0ltL1tBv9vwNZbnIrkCLoRmhfbd2DjqHvSXpLgu1VfHPq-1vmOWCWahNt5rBK_tRy6v2h8-P1CWqyFW1LS4Cn6tYNmxGnVv_N43bcLMGoWS7spo7sGbHd-HaXn3Nfg9OwsH9aEzQ_Ob-OA0bpGZgLYl_djb9OsE9j5z6PPI_v35XMY54HnGf7WnLUfmWbJMzO9PYq2viEzJxBOdqJmejn9aQUDCkvA-Hnd3B-25cV2WIhz6jLTZF7qymbe1Sa2SiRSapzgvupOEyoYV0PNeWFy7VIkmFM0wnAqVdYB0tePoA1seTsX0ExFIfAlig6GcIbbTJqDQCQVdueCZFBK8Xa6OGNWW5r5xxqiqyZapQeSooL4IXjeh5xdNxkdCrsMCNhJ6e-MS2nKuj_gf1ubdz8EUOUoWCmysW0AygXLR9Ol8EGwuTULXTlwp_7gTCV5ayCJ433eiu_g5Gj-1k7mV4yrhEWB0BuUQGYyITErFcBA8ra1t-nyIkRoiJmglGdflcVXd3PzQe_7voM7jeHez1VO9j_9MTuIHYkFZJShuwPpvO7VO4Ovw-G5XTzdrT_gKnji1M |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1fb9MwED-NFk174T8jMIZBCPESljj_bMTLRFeGKFU1NjHxYjmxDdW2pmpahHjiI_AZ-SScnTRVpU1C4s2Sz4p8vjv_Yp9_B_A84zRPijT1qQkLP-Ym9JkONAK5SCllcsWUq1oyyIZDdnrKRxvwZvkWpuaHaA_crGe4eG0dXE-V2Vuxhn7T01c0zlh6DbqxLSLTgW7vqH8yWJHuxq62Kv55BfaGmS-ZhQK61w5e24-6VrU_bH6krFBFpq5tcRn4XMeybjPq3_y_adyCGw0IJfu11dyGDT25A5sfm2v2u3DmDu7HE4Lmt7DHadggDQNrReyzs9nXEvc8cm7zyP_8-l3HOGJ5xG22p67G1WuyTy70XGKvbIhPSGkIzlWVF-OfWhFXMKS6Byf9g-O3h35TlcEvbEabr_LMaEkDaSKteChZyqnM8sRwlfCQ5twkmdRJbiLJwogZFcuQobRxrKN5Et2HzqSc6AdANLUhIHYU_TFCG6lSyhVD0JWpJOXMg5fLtRFFQ1luK2eci5psmQpUnnDK8-BZKzqteTouE3rhFriVkLMzm9iWJeLz8J34NOgdfeHHkUDB3TULaAfQhAU2nc-DnaVJiMbpK4E_dwzhaxzFHjxtu9Fd7R2MnOhyYWWSCI0VYbUH5AoZjIkx44jlPNiurW31fYqQGCEmasYZ1dVzFYcHI9d4-O-iT2Bz1OuLwfvhh0ewhdCQ1jlKO9CZzxb6MVwvvs_H1Wy3cbS_8qMsxw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Albumin+infusion+in+patients+undergoing+large-volume+paracentesis%3A+A+meta-analysis+of+randomized+trials&rft.jtitle=Hepatology+%28Baltimore%2C+Md.%29&rft.au=Bernardi%2C+Mauro&rft.au=Caraceni%2C+Paolo&rft.au=Navickis%2C+Roberta+J.&rft.au=Wilkes%2C+Mahlon+M.&rft.date=2012-04-01&rft.pub=Wiley+Subscription+Services%2C+Inc.%2C+A+Wiley+Company&rft.issn=0270-9139&rft.eissn=1527-3350&rft.volume=55&rft.issue=4&rft.spage=1172&rft.epage=1181&rft_id=info:doi/10.1002%2Fhep.24786&rft.externalDBID=n%2Fa&rft.externalDocID=ark_67375_WNG_SLDRZ9T3_6 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0270-9139&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0270-9139&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0270-9139&client=summon |